CN Patent

CN102481250B — 舌下和口腔膜组合物

Assigned to Aquitif Therapy Co · Expires 2016-10-19 · 10y expired

What this patent protects

本发明涉及用于在患者中治疗多种症状(包括治疗患者所遭受的疼痛)的产品和方法。本发明更具体地涉及自支持的剂型，所述剂型提供活性剂，同时提供剂型足够的口黏附。此外，本发明提供了用于降低转用滥用活性剂之可能性的剂型。

USPTO Abstract

本发明涉及用于在患者中治疗多种症状(包括治疗患者所遭受的疼痛)的产品和方法。本发明更具体地涉及自支持的剂型，所述剂型提供活性剂，同时提供剂型足够的口黏附。此外，本发明提供了用于降低转用滥用活性剂之可能性的剂型。

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102481250B
Jurisdiction: CN
Classification: —
Expires: 2016-10-19
Drug substance claim: No
Drug product claim: No
Assignee: Aquitif Therapy Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.